HomeIPHYF • OTCMKTS
add
Innate Pharma SA
Previous close
$2.90
Year range
$1.28 - $2.90
Market cap
160.49M USD
Avg Volume
58.00
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 6.17M | -69.29% |
Operating expense | 4.79M | 4.79% |
Net income | -12.38M | -1,541.44% |
Net profit margin | -200.60 | -4,797.89% |
Earnings per share | — | — |
EBITDA | -12.78M | -1,007.13% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 91.80M | 3.27% |
Total assets | 151.50M | -23.89% |
Total liabilities | 122.70M | -13.09% |
Total equity | 28.80M | — |
Shares outstanding | 80.95M | — |
Price to book | 8.06 | — |
Return on assets | -21.71% | — |
Return on capital | -51.15% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -12.38M | -1,541.44% |
Cash from operations | 1.52M | 126.48% |
Cash from investing | 466.00K | 478.86% |
Cash from financing | -2.16M | -247.27% |
Net change in cash | -307.50K | 95.20% |
Free cash flow | -7.03M | -428.30% |
About
Founded
1999
Website
Employees
168
